Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune imprinting as a barrier to effective COVID-19 vaccines
Julia N. Faraone, Shan‐Lu Liu
Cell Reports Medicine (2023) Vol. 4, Iss. 11, pp. 101291-101291
Open Access | Times Cited: 11

Showing 11 citing articles:

Distinct patterns of SARS-CoV-2 BA.2.87.1 and JN.1 variants in immune evasion, antigenicity, and cell-cell fusion
Pei Li, Yajie Liu, Julia N. Faraone, et al.
mBio (2024) Vol. 15, Iss. 5
Open Access | Times Cited: 26
Neutralization and Stability of JN.1-derived LB.1, KP.2.3, KP.3 and KP.3.1.1 Subvariants
Pei Li, Julia N. Faraone, Cheng Chih Hsu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 7
Three SARS-CoV-2 spike protein variants delivered intranasally by measles and mumps vaccines are broadly protective
Yuexiu Zhang, Michelle Chamblee, Jiayu Xu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Molecular and genetic characteristic of some Omicron variants of the SARS-CoV-2 virus and prospects for vaccine prevention of COVID-19
В. І. Задорожна, N.P. Vynnyk, Anton Gerilovych
One Health Journal (2025) Vol. 3, Iss. I, pp. 5-21
Closed Access
Intradermal delivery of SARS-CoV-2 RBD3-Fc mRNA vaccines via a needle-free injection system induces robust immune responses in rats
Cenrong Wang, Xin Tang, Chenghan Jiang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Distinct Patterns of SARS-CoV-2 BA.2.87.1 and JN.1 Variants in Immune Evasion, Antigenicity and Cell-Cell Fusion
Pei Li, Yajie Liu, Julia N. Faraone, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Finite immune imprinting on neutralizing antibody responses to Omicron subvariants by repeated vaccinations
Xuedong Song, Guo‐Jian Yang, Chao Shi, et al.
International Journal of Infectious Diseases (2024) Vol. 147, pp. 107198-107198
Closed Access | Times Cited: 1
Neutralizing antibody response to SARS‐CoV‐2 bivalent mRNA vaccine in SIV‐infected rhesus macaques: Enhanced immunity to XBB subvariants by two‐dose vaccination
Julia N. Faraone, X. Wang, Panke Qu, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 3
Open Access
Protection of Omicron bivalent vaccine, previous infection, and their induced neutralizing antibodies against symptomatic infection with Omicron XBB.1.16 and EG.5.1
Shohei Yamamoto, Kouki Matsuda, Kenji Maeda, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Protection of Omicron bivalent vaccine, previous infection, and their induced neutralizing antibodies against symptomatic infection with Omicron XBB.1.16 and EG.5.1
Shohei Yamamoto, Kouki Matsuda, Kenji Maeda, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 9
Open Access
Steps towards licensure of self-amplifying RNA vaccines
M. Wilbrink, Sander Herfst, Rory D. de Vries
The Lancet Infectious Diseases (2024)
Closed Access
Page 1

Scroll to top